I'm also now thinking of the other possibilities - e.g., if it can be shown that the reduction of intracranial pressure via Exenatide/ Presendin leads to an improvement in cognition in diseases where cognitive impairment is prevalent in the early stages (e.g., ischemic stroke, traumatic brain injury), it'll be a game changer. Very exciting
I'm also now thinking of the other possibilities - e.g., if it...
Add IXC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
6.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $4.960M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 11800 | 6.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.0¢ | 38000 | 1 |
View Market Depth
| Last trade - 14.40pm 25/12/2024 (20 minute delay) ? |
| IXC (ASX) Chart |
Day chart unavailable
